Sébastien Koné
About Sébastien Koné
Sébastien Koné is the Associate Medical Director Hematology Multiple Myeloma at Bristol Myers Squibb in Rueil-Malmaison, Île-de-France, France, with over 15 years of experience in medical management roles across various therapeutic areas.
Current Position at Bristol Myers Squibb
Sébatien Koné holds the role of Associate Medical Director Hematology Multiple Myeloma at Bristol Myers Squibb. He has been serving in this position since October 2020. His responsibilities involve overseeing medical affairs related to hematologic malignancies, specifically focusing on multiple myeloma. Sébatien is based in Rueil-Malmaison, Île-de-France, France.
Professional Experience at Celgene
Sébatien Koné worked at Celgene as the Senior Manager Medical Affairs - Hematology Myeloma from 2016 to 2020. During his four-year tenure, he focused on managing medical affairs for hematology myeloma products, including key drugs such as Revlimid and Pomalidomid. His role involved developing medical strategies and supporting the launch and lifecycle management of these therapies.
Roles at Roche in Digestive Cancers
Sébatien served as Senior Medical Manager - Digestive Cancers at Roche from 2011 to 2016, based in Région de Boulogne-Billancourt, France. For five years, he worked on significant oncology products such as Avastin, Tecentriq, Perjeta, and Kadcyla. His responsibilities included overseeing medical management and developing strategies for these drugs in the field of digestive cancers.
Experience in Nephrology and Rheumatology at Roche
Sébatien Koné has extensive experience in nephrology and rheumatology through his roles at Roche. From 2006 to 2011, he served as Medical Manager in nephrology, anemia, and transplantation, working with drugs like NeoRecormon, Mircera, and Celcept. He also spent one year (2005-2006) as Medical Manager in rheumatology, focusing on Mabthera. All these positions were based in Région de Boulogne-Billancourt, France.
Extensive Experience in Medical Management
With over 15 years of experience in medical management roles, Sébatien Koné has built a strong background in managing medical affairs across various therapeutic areas. His extensive work spans hematology, digestive cancers, nephrology, anemia, transplantation, and rheumatology. He has contributed to the development and lifecycle management of numerous significant drugs, making him well-versed in both solid tumors and hematologic malignancies.